Glucose tolerance during pulmonary exacerbations in children with cystic fibrosis

J. Widger, M. Oliver, F. Cameron, S. Ranganathan, P. Robinson (Melbourne, Australia)

Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Session: Cystic fibrosis: new basic, clinical and bacteriological knowledge
Session type: Poster Discussion
Number: 4555
Disease area: Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Widger, M. Oliver, F. Cameron, S. Ranganathan, P. Robinson (Melbourne, Australia). Glucose tolerance during pulmonary exacerbations in children with cystic fibrosis. Eur Respir J 2011; 38: Suppl. 55, 4555

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exercise tolerance in adults with cystic fibrosis
Source: Annual Congress 2008 - Cystic fibrosis: a disease with many aspects
Year: 2008


Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis
Source: ERJ Open Res, 4 (1) 00111-2017; 10.1183/23120541.00111-2017
Year: 2018



Acute exercise in cystic fibrosis patients increases neutrophilic pulmonary inflammation
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research
Year: 2012


Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations
Source: Eur Respir J 2015; 46: 1055-1064
Year: 2015



Evaluation of functional capacity and pulmonary functions during acute pulmonary exacerbation in children with cystic fibrosis
Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases
Year: 2020


Pulmonary hypertension in cystic fibrosis patients
Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools
Year: 2008


Predictive factors for severe pulmonary exacerbations in patients with cystic fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 715s
Year: 2006

Early detection of pulmonary exacerbations in children with cystic fibrosis by electronic home monitoring of symptoms and lung function
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016


Incidence and resource utilisation of pulmonary exacerbations in patients with cystic fibrosis in the UK
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010

Symptom duration and the lung clearance index in children with cystic fibrosis and pulmonary exacerbations
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019

Pulmonary function of infants with cystic fibrosis, with and without respiratory symptoms
Source: Eur Respir J 2002; 20: Suppl. 38, 529s
Year: 2002

Airway infection, systemic inflammation and lung clearance index in children and adults with cystic fibrosis
Source: Eur Respir J, 51 (2) 1701704; 10.1183/13993003.01704-2017
Year: 2018



Lung clearance index during pulmonary exacerbation in school-age children with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013


Changes in pulmonary function tests following antibiotics in infants with pulmonary exacerbation of cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment
Year: 2013


Assessing response to treatment of exacerbations of bronchiectasis in adults
Source: Eur Respir J 2009; 33: 312-318
Year: 2009



Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis
Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases
Year: 2018

Pulmonary arterial enlargement is a predictor of higher risk of exacerbations in non-cystic fibrosis bronchiectasis patients
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021


Vitamin D serum level and pulmonary exacerbations in children with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013


Indicators of pulmonary exacerbation in adults with cystic fibrosis (CF)
Source: Annual Congress 2011 - Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation
Year: 2011



Inflammatory markers can predict pulmonary exacerbations of cystic fibrosis
Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers
Year: 2017